EcoDrugPlus

Carbonic Anhydrase Iv A

Ensembl ID : ENSMMDG00005019779
Gene Symbol: CA4A
1 Cross references
212 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSMMDG00005018528
Gene Symbol: CA4C
1 Cross references
78 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSMMDG00005018526
Gene Symbol: CA4C
1 Cross references
78 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSMMDG00005001354
Gene Symbol: CA14
1 Cross references
210 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSMMDG00005009313
Gene Symbol: CSNK1E
3 Cross references
211 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSMMDG00005024608
Gene Symbol: CSNK1E
1 Cross references
196 Possible Orthologues:

Caspase 9

Ensembl ID : ENSMMDG00005014019
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSMMDG00005008931
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSMMDG00005021260
Gene Symbol: CTSC
3 Cross references
237 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSMMDG00005015313
Gene Symbol: CTSK
1 Cross references
234 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSMMDG00005018098
Gene Symbol: CTSK
1 Cross references
234 Possible Orthologues:

Cathepsin K-Like

Ensembl ID : ENSMMDG00005018323
Gene Symbol: LOC115373209
3 Cross references
234 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).